PMC:7696151 / 20177-20417 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"568","span":{"begin":64,"end":67},"obj":"Chemical"},{"id":"576","span":{"begin":106,"end":121},"obj":"Disease"},{"id":"577","span":{"begin":169,"end":173},"obj":"Disease"}],"attributes":[{"id":"A568","pred":"tao:has_database_id","subj":"568","obj":"MESH:D006886"},{"id":"A576","pred":"tao:has_database_id","subj":"576","obj":"MESH:D007239"},{"id":"A577","pred":"tao:has_database_id","subj":"577","obj":"MESH:D010146"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"mained until the end of the trial (six weeks). It was seen that HCQ had no benefit in the early stages of CHIKV infection and also in the reduction of the VAS (used for pain assessment) and in the improvement of Barthel’s indexes (used for "}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T15","span":{"begin":169,"end":173},"obj":"Phenotype"}],"attributes":[{"id":"A15","pred":"hp_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/HP_0012531"}],"text":"mained until the end of the trial (six weeks). It was seen that HCQ had no benefit in the early stages of CHIKV infection and also in the reduction of the VAS (used for pain assessment) and in the improvement of Barthel’s indexes (used for "}